Extracorporeal shock wave lithotripsy for gallstones
When a new and expensive machine enters medical practice, especially one whose mechanism appears magical, doctors, patients, and the media seem to abandon their critical faculties and give it a welcome which they seldom afford to a new drug, especially one that had not been through rigorous safety testing.
Add a promise of treating a common disease without an operation, with a private health care system, and the stage is set for all sorts of short and long term problems as well as possible successes.
Lithotripsy for renal stones was first used in 1981. The original Dornier machine involved the patient being immersed in a water bath under a general anaesthetic. The shockwave was produced by a spark gap technique and transmitted through the water to the patient. Second generation machines use a water contact but not immersion with three methods of producing the shock waves: spark gap, piezo electric and electromagnetic. Many ofthe newer lithotripters can be used for both renal and biliary stones, but with two important implications. Renal stone fragments only have to pass down the ureter to be washed out by the urine, but gallstone fragments have to negotiate the cystic duct, the common duct, and the sphincter of Oddi. Removing a kidney could have major long term repercussions, but removing the gallbladder is in a different league and the pathophysiology of recurrent stones is different in the two systems.
There is no doubt that gallstones in the gallbladder', and in the common bile duct2, can be broken into fragmentsin some cases as small as 2mm in diameter-but results of in vitro fragmentation are not always reproduced in vivo.
Paumgartner and colleagues' who have the longest experience, found that by combining lithotripsy with bile salt therapy, 66% ofpatients with small solitary stones but only 18% of patients with multiple stones had cleared all fragments within 4-8 months. By 12-18 months the figures were 84% and 63%. They selected the stones by the same criteria as for dissolution therapy (ie not more than three, non calcified, with a total stone volume of less than 4000mm3, in a functioning gallbladder). Is lithotripsy then merely an aid to dissolution? If so it may speed dissolution by about 3-4-fold, but no randomized controlled trial has so far been done. Studies are in process in Britain, the USA and Canada to see if lithotripsy without bile salts is effective and some of this work is controlled. Other studies are being done to see whether larger and more stones can be treated and whether calcification is an absolute contra-indication. Certainly many calcified stones can be fragmented especially those with surface (ring) calcification, but bile salts will not dissolve the calcified fragments. On present criteria only about 15% of all symptomatic stones are suitable for treatment. Pain and not flatulent dyspepsia is the criteria for treatment. No one so far is advocating treatment of asymptomatic stones. Side effects include biliary colic in about one third of patients as stone fragments pass down the common bile duct, but surprisingly, acute pancreatitis is rare.
A mucocele or empyema may occur if a fragment impacts in the cystic duct. There is early temporary damage to the mucosa3, and to the lung if it is incorporated in the shock wave path, but little is known about long term tissue damage. Recurrence of stones is unlikely to be less than that after dissolution (about 50% at 5 years) and could be greater if many small particles are left to act as nucleating agents. It is not clear yet whether the presence of stones or the diseased mucosa is the most important factor in the late development ofcarcinoma; but there must be anxiety about leaving a diseased gallbladder for 40 years with intermittent stone formation even if lithotripsy is repeated every few years to break up the stones. It is surprising that at present there are only one or two formal randomized controlled trials4, comparing lithotripsy with the existing very effective standard treatment (ie cholecystectomy) looking not only at clearance of stones, but symptomatic relief and cost effectiveness for hospital and patient. (The machines cost between 0.5 and 0.75 million pounds.) If 80% of patients with gallstones are symptom free, one must ask if clearance of stones or removal of symptoms is the most important outcome of treatment. Unfortunately, in many countries there has been competition between different specialists groups, radiological, surgical and gastroenterological about who should have the lithotripter, and this has clouded some of the scientific questions that need to be answered. Ideally the patient should be treated by a team of specialists with endoscopic, radiological and surgical skills and we must continue to remember that the gallbladder is attached to a patient! In the near future, lithotripsy will have to be compared with other minimally invasive techniques for removing gallstoneseither by percutaneous, trans-hepatic catheters and dissolution with MTBE or types of cholecystostomy through very small incisions, with or without ablation of the gallbladder mucosa. Surgeons are learning to remove gallbladders leaving very small scars and, if the only advantage of lithotripsy is avoiding a scar, the initial enthusiasm may well be tempered. All treatments that leave the gallbladder intact in the patient will be less than ideal until a simple long term way of stopping the recurrence of gallstones is found. The search must continue into the way gallstones form and how they can be prevented. Meanwhile, extracorporeal lithotripsy may be most valuable for elderly patients, those with other diseases that make operation particularly risky and those with a few stones in a normal gallbladder.
Alan G Johnson Professor of Surgery, University of Sheffield
